3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
NET
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Classical hematology
1
Conditions
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Hodgkin Disease
2
Multiple Myeloma
1
Lymphoma, T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Leukemia, T-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Large B-cell Lymphoma
1
Febrile Neutropenia
1
Disease
1
Aggression
1
Interventions
obinutuzumab
2
venetoclax
1
ofatumumab
1
neratinib
1
idelalisib
1
ibrutinib
1
Vindesine
1
Vincristine
1
Triamcinolone Acetonide
1
Transcatheter Aortic Valve Replacement
1
Th1-Th2 Balance
1
Surveys and Questionnaires
1
Rituximab
1
Prednisone
1
Positron Emission Tomography Computed Tomography
1
Nivolumab
1
Mechlorethamine
1
Interviews as Topic
1
HIV Testing
1
Doxorubicin
1
Diffusion Magnetic Resonance Imaging
1
Cyclophosphamide
1
Bleomycin
1
Bexarotene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Disease
×
Positron Emission Tomography Computed Tomography
×
Lymphoid
×
Clear all
NCT03429387
2022-05-17
PIPPIN
Peter MacCallum Cancer Centre, Australia
Phase NA
Completed
147 enrolled